David A. Siegel Magenta Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.62 - $0.79 $14,474 - $18,443	23,346 Added 15.15%	177,400 $134,000
Q1 2023 May 15, 2023	SELL	$0.41 - $0.86 $39,542 - $82,943	-96,446 Reduced 38.5%	154,054 $121,000
Q4 2022 Feb 14, 2023	SELL	$0.36 - $1.59 $13,284 - $58,671	-36,900 Reduced 12.84%	250,500 $100,000
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $104,454 - $173,261	-82,900 Reduced 22.39%	287,400 $405,000
Q2 2022 Aug 15, 2022	BUY	$0.97 - $3.08 $131,726 - $418,264	135,800 Added 57.91%	370,300 $444,000
Q1 2022 May 16, 2022	BUY	$2.55 - $5.23 $52,784 - $108,261	20,700 Added 9.68%	234,500 $680,000
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $23,036 - $43,316	-5,200 Reduced 2.37%	213,800 $947,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $76,482 - $124,614	12,600 Added 6.1%	219,000 $1.59 Million
Q2 2021 Aug 16, 2021	SELL	$9.76 - $14.15 $8,784 - $12,735	-900 Reduced 0.43%	206,400 $2.02 Million
Q1 2021 May 17, 2021	SELL	$7.66 - $13.38 $39,832 - $69,576	-5,200 Reduced 2.45%	207,300 $2.45 Million
Q4 2020 Feb 16, 2021	BUY	$6.1 - $7.94 $159,820 - $208,028	26,200 Added 14.06%	212,500 $1.67 Million
Q3 2020 Nov 16, 2020	BUY	$6.52 - $8.94 $1.21 Million - $1.67 Million	186,300 New	186,300 $1.27 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.